Have a personal or library account? Click to login
Chemosuppressive activities in in vivo studies of Plasmodium falciparum-infected mice using isolated oil of Stigmaphyllon ovatum (Amazon vine) Cav. Cover

Chemosuppressive activities in in vivo studies of Plasmodium falciparum-infected mice using isolated oil of Stigmaphyllon ovatum (Amazon vine) Cav.

Open Access
|Feb 2017

References

  1. [1]. D.A. Joy, X. Feng1, J. Mu, T. Furuya, K. Chotivanich, A.U. Krettli, M. Ho, A. Wang, N. J. White, Edward Suh, Peter Beerli, X. Su, Early origin and recent expansion of Plasmodium falciparum, Science 300 (2003) 318. DOI: 10.1126/science.108144910.1126/science.1081449
  2. [2]. FMOH. National Antimalarial Treatment Guidelines. Federal Ministry of Health, National Malaria and Vector Control Division, Abuja-Nigeria.25 (2005).
  3. [3]. K.G. Kuhn, D.H. Campbell-Lendrum, B. Armstrong, C.R. Davies, Malaria in Britain: past, present and the future. Proc. Natl. Acad. Sci. 100 (2003) 9997. DOI: 10.1073/pnas.123368710010.1073/pnas.1233687100
  4. [4]. F. Olojo. (Personal Communication dated 7th May (2006).
  5. [5]. P. Rasoanaivo, A. Petitjean, S. Manga-Urverg, A. Rakoto Ratsimamanga, Medicinal Plants used to treat malaria in Madagascar, J. Ethnopharmacol. 2 (1992) 117. DOI: 10.1016/0378-8741(92)90070-810.1016/0378-8741(92)90070-8
  6. [6]. C.K Kokate, A.P. Purohit, and S.B. Gokhale. Pharmacognosy, Published by Nirali Prakashan, Pune, pp. 616 - 617 (2009).
  7. [7]. W.C Evans and G.E Trease, Pharmacognosy, Published by W.B. Saunders, Edinburgh, pp. 193 - 407 (2002).
  8. [8]. D. Lorke, A new approach to practical acute toxicity test, Arch. Toxicol. 54 (1983) 275. DOI: 10.1007/BF0123448010.1007/BF012344806667118
  9. [9]. A. Javeed, Y. Hou, K. Duan, B. Zhang, H. Shen, Y. Cao, Y. Zhao, Aspirin significantly decreases the nonopsonic phagocytosis and immunogenicity of macrophages in mice, Infl. Res. 60 (2011) 389. DOI: 10.1007/s00011-010-0283-410.1007/s00011-010-0283-421116834
  10. [10]. A. Bellahsene, A. Forgren, Effect of Doxycycline on immune response in mice, Infect. Immun. 48 (1985) 556.
  11. [11]. O.S. Imade, O. Iyekowa, M.O. Edema, F.I. Akinnibosun, B.H. Oladeinde, M.A. Olley, Cost-effective scheme developed for studying human malaria caused by Plasmodium falciparum, J. Nat. Sci. Res. 2 (2012) 1.
  12. [12]. A. Moreno, E. Badell, N. Van-Rooijen, P. Druilhe, Human malaria in ummunocompromised mice: New in vivo model for chemotherapy studies, Antimicrob. Agents Ch. 45 (2001) 1847. Doi:10.1128/AAC.45.6.1847-1853.200110.1128/AAC.45.6.1847-1853.20019055611353636
  13. [13]. W. Trager, J.B. Jensen, Human malaria parasites in continuous culture, Science 93 (1976) 673.
  14. [14]. C. Lambros, J. Vanderberd, Synchronization of P. falciparium erythrocyte stages in culture, J. Parasitol. 65 (1979) 418.
  15. [15]. O.W. Schlam, N.C. Jain, E.J. Carroll, Veterinary Hematology, 3rd Edition, Lea&Fibinger Publisher, USA, 207-209 (1975).
  16. [16]. WHO. Basic Malaria Microscopy Part 1. Learner’s Guide, 2nd Edition, WHO Press, Geneva, 21 - 68, (2009).
  17. [17]. A. Moody, Rapid diagnostic tests for malaria parasites, Clin. Microbiol. Rev. 15 (2002) 66. DOI: 10.1128/CMR.15.1.66-78.200210.1128/CMR.15.1.66-78.200211806011781267
  18. [18]. A.S. Bassey, J.E. Okokon, E.I. Etim, F.U. Umoh, E. Bassey, Evaluation of the in vivo antimalarial activity of ethanolic leaf and stembark extracts of Anthocleista djalonenis, Indian J. Pharmacol. 41 (2009) 258. DOI: 10.4103/0253-7613.5992410.4103/0253-7613.59924284649920407556
DOI: https://doi.org/10.1515/auoc-2017-0001 | Journal eISSN: 2286-038X | Journal ISSN: 1583-2430
Language: English
Page range: 1 - 6
Submitted on: Nov 13, 2016
Accepted on: Jan 22, 2017
Published on: Feb 10, 2017
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:

© 2017 Osaro Iyekowa, Mary Olire Edema, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.